Sepio Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$718K Sell
781
-64
-8% -$64.9K 0.04% 211
2025
Q4
$908K Buy
845
+136
+19% +$130K 0.05% 177
2025
Q3
$541K Buy
+709
New +$528K 0.03% 210
2024
Q4
Sell
-288
Closed -$255K 304
2024
Q3
$255K Buy
+288
New +$259K 0.02% 272
2024
Q1
Sell
-500
Closed -$291K 296
2023
Q4
$291K Buy
+500
New +$292K 0.02% 253
2023
Q1
Sell
-568
Closed -$208K 355
2022
Q4
$208K Sell
568
-129
-19% -$45.7K 0.02% 324
2022
Q3
$228K Buy
697
+40
+6% +$12.7K 0.02% 300
2022
Q2
$213K Buy
+657
New +$197K 0.02% 315

Other funds holding LLY

Sepio Capital's LLY Position: Q1 2026 in Review

Sepio Capital reduced its Eli Lilly (LLY) stake by 7.6% in Q1 2026, selling an estimated $64.9K and leaving 781 shares worth $718K. The position accounts for 0.04% of the portfolio, ranked #211.

Sepio Capital first reported a position in LLY in Q2 2022 and has held it in 8 quarters since. The position peaked at $908K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Sepio Capital held 781 shares of Eli Lilly worth $718K as of Q1 2026.
  • Sepio Capital sold 64 Eli Lilly shares in Q1 2026, an estimated $64.9K.
  • Eli Lilly made up 0.04% of Sepio Capital's portfolio in Q1 2026, its #211 holding.
  • Sepio Capital first reported a position in Eli Lilly in Q2 2022 and has held it in 8 quarters since.
  • Sepio Capital's Eli Lilly position peaked at $908K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Sepio Capital's 13F filing for Q1 2026, filed 13 May 2026.